Form 8-K - Current report:
SEC Accession No. 0001193125-25-158454
Filing Date
2025-07-14
Accepted
2025-07-14 08:05:30
Documents
14
Period of Report
2025-07-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d940113d8k.htm   iXBRL 8-K 24749
2 EX-99.1 d940113dex991.htm EX-99.1 9471
6 GRAPHIC g940113g0711211706425.jpg GRAPHIC 4960
  Complete submission text file 0001193125-25-158454.txt   155290

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20250714.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20250714_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20250714_pre.xml EX-101.PRE 10812
17 EXTRACTED XBRL INSTANCE DOCUMENT d940113d8k_htm.xml XML 3539
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 251120185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)